3,4-Dihydro-2H-pyran

Market Intelligence Report on 3,4-Dihydro-2H-pyran (DHP) – Recent Commercial Dynamics

I. Market Price Dynamics

1. Domestic Prices
- As of June 23, 2026, the ex-factory price for domestically produced 98% purity 3,4-dihydro-2H-pyran in Suzhou City, Jiangsu Province, stood at RMB 145,000 per metric ton, showing no significant fluctuation compared to prior levels.
- On June 28, 2026, Jinjinle Chemical Co., Ltd. quoted RMB 9 per kilogram for 99% purity material (packaged in 5 kg or 1 kg units), reflecting pricing differentiation for small-batch procurement.
- On June 25, 2026, Anhui Wehe Chemical Technology Co., Ltd. listed its industrial-grade product (99.5% purity, supplied in 232 kg drums) at 'price upon negotiation', highlighting flexibility in bulk transactions.

2. International Market Reference
- The global market generated approximately USD 46.2 million in revenue in 2025 and is projected to maintain steady growth from 2026 to 2032. However, no recent international price data has been disclosed; users should monitor exchange rate volatility and trade policy developments.

II. Supply–Demand Analysis

1. Supply Side
- Key Producers: BASF, Kawaken Fine Chemicals, Zhangjiagang Free Trade Zone Kailite Chemical Co., Ltd., Shandong Yinuo Biomass Materials Co., Ltd., and Qingquan Co., Ltd. dominate the market, collectively holding over 60% of total market share among the top five manufacturers.
- Production Capacity Distribution: North America, Europe, China, and Japan constitute the world’s primary production regions, accounting for over 90% of global capacity. China’s capacity expansion has been particularly notable; it already commands a substantial share of global output as of 2023 and is expected to further increase its share by 2030.
- Purity Structure: High-purity grades (≥98%) account for more than 80% of total supply and are primarily used in pharmaceutical intermediates and high-end organic synthesis. Lower-purity grades (<98%) offer cost advantages and mainly serve small- and medium-sized chemical enterprises.

2. Demand Side
- Pharmaceutical Intermediates: The largest application segment, contributing over 60% of total demand. Annual global R&D investment in innovative drugs grows at an average rate of 8%, driving surging demand for critical intermediates—especially for antimicrobial and antiviral agents.
- Hydroxyl Protecting Agent: Widely adopted in fragrance, dye, and polymer material synthesis due to its ability to form stable tetrahydropyranyl ether structures that protect reactive hydroxyl groups.
- Other Applications: Includes use as a solvent and as a raw material for resin synthesis; DHP can be further transformed via hydrogenation or oxidation into downstream chemicals such as glutaric dialdehyde and glutaric acid.

III. Growth Drivers and Challenges

1. Growth Drivers
- Pharmaceutical Industry Demand: Aging populations and evolving disease profiles globally are expanding the pharmaceutical market. Rich innovation pipelines for novel therapeutics continue to elevate demand for high-purity intermediates.
- Technological Advancement: Rising efficiency and purity requirements in fine chemical synthesis are increasing adoption of high-purity DHP—particularly in hydroxyl protection steps—while advances in green synthesis favor reagents with superior reaction selectivity.
- Industrial Relocation: Global manufacturing capacity is shifting toward the Asia-Pacific region. Countries including China and India are achieving economies of scale through technological upgrades, thereby reducing costs and enhancing supply chain resilience.

2. Potential Challenges
- Competitive Intensity: Although market concentration is relatively high, new entrants may disrupt the status quo via technological breakthroughs or cost advantages.
- Environmental Pressures: Production involves highly flammable materials, imposing constraints on transportation and storage. Increasingly stringent environmental regulations also raise operational compliance costs.
- Substitution Risk: Alternative materials exist for certain applications; continuous innovation is essential to sustain competitive positioning.

IV. Price Forecast and Trend Outlook

1. Short Term (Second Half of 2026)
- Price Stability: The current domestic ex-factory price of RMB 145,000/ton reflects balanced supply and demand; no significant short-term fluctuations are anticipated.
- Regional and Volume-Based Pricing Divergence: Small-batch quotations (e.g., RMB 9/kg) differ from bulk transaction terms (‘price upon negotiation’), underscoring market segmentation and flexibility.

2. Medium Term (2027–2029)
- Moderate Growth: The global market size is forecast to expand from USD 46.2 million in 2025 to USD 49.0 million by 2029, representing a CAGR of ~2.3%. China’s rising market share will provide underlying support for domestic pricing.
- Structural Optimization: Growing demand for high-purity grades will gradually lift the average selling price; lower-purity grades may experience modest adjustments under cost pressure.

3. Long Term (2030–2032)
- Technology-Driven Efficiency: Optimized catalytic synthesis processes and mature green production technologies will reduce manufacturing costs and enhance overall industry competitiveness.
- Demand Upscaling: As pharmaceuticals and fine chemicals advance toward higher value-added segments, the proportion of premium products is expected to rise, potentially shifting the overall price center upward.

V. Key Risk Alerts

1. Demand Volatility: Delays in pharmaceutical R&D pipelines or macroeconomic downturns could dampen end-user demand.
2. Regulatory and Policy Shifts: Stricter environmental regulations or heightened trade barriers may disrupt supply chains.
3. Technological Substitution: Emergence of novel protecting groups or alternative synthetic routes may erode DHP’s competitive edge.